Cargando…
Plasma metabolomics study in screening and differential diagnosis of multiple primary lung cancer
Multiple primary lung cancer (MPLC) is becoming increasingly common in clinical practice. Imaging examination is sometimes difficult to differentiate from intrapulmonary metastasis (IM) or single primary lung cancer (SPLC) before surgery. There is a lack of effective blood biomarkers as an auxiliary...
Autores principales: | Liu, Zixu, Wang, Ling, Gao, Shugeng, Xue, Qi, Tan, Fengwei, Li, Zhili, Gao, Yushun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389222/ https://www.ncbi.nlm.nih.gov/pubmed/36928390 http://dx.doi.org/10.1097/JS9.0000000000000006 |
Ejemplares similares
-
Plasm Metabolomics Study in Pulmonary Metastatic Carcinoma
por: Liu, Zixu, et al.
Publicado: (2022) -
Comment on ‘Plasma metabolomics study in screening and differential diagnosis of multiple primary lung cancer’
por: Fang, Tianzheng, et al.
Publicado: (2023) -
A commentary on ‘Plasma metabolomics study in screening and differential diagnosis of multiple primary lung cancer’
por: Hu, Zongtao, et al.
Publicado: (2023) -
Uniportal versus multiportal thoracoscopic sleeve lobectomy for the surgical treatment of centrally located lung cancer: a single institution experience
por: Zhao, Jun, et al.
Publicado: (2020) -
Single‐cell RNA sequencing analysis reveals transcriptional heterogeneity of multiple primary lung cancer
por: Guo, Wei, et al.
Publicado: (2023)